According to a new report, published by KBV research, The Global Genotyping Market size is expected to reach $30.9 billion by 2028, rising at a market growth of 14.7% CAGR during the forecast period.
The Reagents & Kits segment acquired maximum revenue share in the Global Genotyping Market by Product in 2021, thereby, achieving a market value of $18.6 billion by 2028. Due to rising genetic testing demand, increased R&D investments, and higher genotyping testing volumes, these products make it simple and dependable to look at genetic variation in people, animals, species, and individual genes. High-resolution melt analysis (HRM), Amplification fragment length polymorphism (AFLP), SNP genotyping, animal DNA extraction and qPCR genotyping are among the kits available.
The Agricultural Biotechnology segment is showcasing a CAGR of 15.8% during (2022 - 2028). Researchers are employing genotype and next-generation genotyping technology to better understand the genetic variation that influences phenotypes in agricultural species. Trait screening, marker-assisted backcrossing, and parentage testing are all made possible by Agri genomics. Researchers and breeders can use technology to assess and predict genetic merit
The Diagnostics & Research Laboratories segment is generating highest revenue in the Global Genotyping Market by End Use in 2021; thereby, achieving a market value of $13.8 billion by 2028. The rising incidence of cancer is likely to boost demand for diagnostic tests such as cancer genotyping assays as a result of the increasing use of genotyping tools in research and the growing need to diagnose genetic illnesses and cancers.
The Capillary Electrophoresis segment has shown growth rate of 15.7% during (2022 - 2028). Capillary electrophoresis is an experimental technique that utilizes an applied voltage to separate ions based on their ionic charge. Electrophoretic mobility is influenced by the molecule's charge, viscosity, and atom radius. CE (capillary electrophoresis) is a new technique that can speed up and automate DNA typing procedures. Despite the widespread usage of slab-gel electrophoresis, there are significant advantages to studying DNA in a capillaries format.
North America is the fastest growing region in the Global Genotyping Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $11.6 billion by 2028. The Europe market is estimated to witness a CAGR of 14.3% during (2022 - 2028). Additionally, The Asia Pacific market would experience a CAGR of 15.2% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/genotyping-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of F. Hoffmann-La Roche Ltd., Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Bio-Rad Laboratories, Inc., Eurofins Scientific Group, and Fluidigm Corporation.
By Product
By Application
By End Use
By Technology
By Geography
Companies Profiled
Unique Offerings 
